Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES or MYELOPROLIFERATIVE disorderS.
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 2 PHASE2. Research is primarily sponsored by academic and government institutions.
1 publication has been identified in PubMed for myelodysplastic/myeloproliferative disease. Research spans Epidemiology / Natural History (100%).
Gou X (2025). [PMID: 40171258](https://pubmed.ncbi.nlm.nih.gov/40171258/). *Frontiers in oncology*. [Epidemiology / Natural History]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 8:19 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center